This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.
Customer Service
Toll-Free Phone:
1-800-372-1033
M-F, 8:30 a.m. - 7:00 p.m. ET
(excluding most federal holidays)
Online Support Forms
Major Topics Covered
Reforms to Hatch-Waxman Act
Fraud and abuse investigations
FDA regulation of drug company advertising and marketing
FTC antitrust enforcement actions
Growth of generic drugs
State Medicaid formularies
Biotechnology patents
Medicare drug benefit debate
Drug pricing lawsuits by states and consumers
Pharmaceutical Law & Industry Report ®
Details
What this service is:
Stay informed of regulatory and litigation developments affecting the pharmaceutical and biotech industries.
What it helps you do:
Follow major actions at the federal and state level that focus on intellectual property/patent issues, drug pricing and reimbursement, FDA oversight, and Federal Trade Commission antitrust enforcement.
Keep current with marketplace news on the forces behind escalating costs and the responses from the public and private sectors.
Understand how health plans, pharmacy benefit managers, and employers develop and apply drug cost-containment strategies and modifications to health plan benefits.
Stay tuned in with "hot links" to important full-text documents on the Web, such as Federal Register notices, court decisions, and government reports.
Save hours of reading time with analytical articles on emerging case law and current litigation by practicing attorneys.
Rely on reporting that is objective and independent, as well as timely.
Product Structure
Notification: current reports providing news and developments
Formats and Frequency
Print and Web notification formats are issued and available weekly. Print current reports are indexed every six months, cumulating annually. Web current reports are archived to 1/17/2003, with archive coverage of Pharmaceutical Law & Policy Report since 7/12/2001. E-mail summaries, providing the highlights and table of contents for each report, with URLs to full text articles and documents are also available.